Regional application of TNFα in the treatment of cancer: A preclinical-clinical interactive program

Alexander M.M. Eggermont, Eric R. Manusama, Timo L.M. Ten Hagen

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

16 Citaten (Scopus)

Samenvatting

The clinical success of the application of TNF-α in the setting of isolated limb perfusions in patients with advanced sarcomas, melanomas and other tumors has renewed the interest in TNFa as an anticancer drug in man. We have developed an interactive preclinical-clinical TNFa program that explores new methods to use TNFa in various settings or enhance its activity. Thus we have developed regional organ perfusion models and are testing the effectivity of targeting ofTNF to the tumor by means systemic administration of long circulating liposomes. Furthermore various drugs and mechanisms that may enhance the activity of TNFa are under investigation. An overview of this comprehensive program is presented here.

Originele taal-2Engels
Pagina's (van-tot)104-113
Aantal pagina's10
TijdschriftJournal of Inflammation
Volume47
Nummer van het tijdschrift1-2
StatusGepubliceerd - 1995
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Regional application of TNFα in the treatment of cancer: A preclinical-clinical interactive program'. Samen vormen ze een unieke vingerafdruk.

Citeer dit